Aryballe Technologies Appoints Top Consumer Industry Executive Jean-Christophe Simon as New Chairman of the Board to Help Drive Next Phase of Growth
Aryballe Technologies (www.aryballe-technologies.com), the pioneer in digital olfaction, has appointed Dr Jean-Christophe Simon as its Chairman of the Board. He will bring to Aryballe his vision about transformation of food tech and cosmetic industries. Aryballe’s bio-inspired “digital nose” NeOseTM Pro, mimicking the human olfactory receptors that recognize smells, uses sensors to detect, measure and identify several hundreds of odors improving quality control, safety, and sensory evaluation important to multiple industries. Dr Simon will drive Aryballe’s industry expansion as the demand and use applications for this smart sensory technology continues to increase.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180928005201/en/
Aryballe Technologies appoints Jean-Christophe Simon as new Chairman of the Board (Photo: Jean-Christophe Simon)
With more than 25 years in R&D and innovation management, Dr Simon joins Aryballe with a dynamic and proven successful career in the innovation of consumer products for the food, home appliances and cosmetic industries.
“We’re delighted and honored to welcome Jean-Christophe as Aryballe’s Chairman of the Board,” said Sam Guilaumé, Aryballe CEO. “His global industry experience and international vision will have a profound impact on our advancement as a global technology leader in digital olfaction and help position the company for transformative growth.”
“Aryballe’s technology is groundbreaking. I am excited to have the opportunity to build on Aryballe’s success in the food and beverage, fragrance and cosmetic, and automotive industries, and to help expand the reach of Aryballe’s versatile technology,” said Jean-Christophe Simon. “Aryballe has created diverse applications to deliver outstanding industry outcomes, B2B as well as B2C. I look forward to working with this experienced and passionate team to contribute to Aryballe’s next developments as Chairman of the Board.”
Most recently, Dr Simon, since his appointment in 2010, served as the Chief Innovation Officer and Senior Vice-President of the Group Research at Groupe SEB. Dr Simon started his career in public research. He then joined the cosmetic company L’Oréal before moving to Japan and Germany to bring his experience to the Kao group. He has held the position of president and representative director of the Nikon and Essilor International Joint Research Center.
“Jean-Christophe is uniquely suited to serve as Chairman and will play a vital role in capitalizing Aryballe’s recent accomplishments. He has the proven track record and leadership experience to make great strides as we innovate for the future of digital olfaction bringing smell to the forefront of smart technology,” added Tristan Rousselle, Aryballe’s Deputy CEO.
Aryballe, a startup based in Grenoble, France, develops and manufactures bio-inspired odor sensors enabling groundbreaking applications in the food, cosmetics and automotive industries. Founded in 2014, it released its first product, the digital nose NeOseTM Pro in early 2018. Fast, portable and sensitive to hundreds of odors, NeOseTM Pro is used for quality control in the cosmetic industry, new flavors development in the Food & Beverage industry, or materials quality monitoring in the automotive industry.
For further information visit: www.aryballe-technologies.com
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration23.8.2019 20:01:00 CEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced the closing of the global research and development collaboration agreement signed on July 14, 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190823005335/en/ This agreement has received clearance from the U.S. Federal Trade Commission under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and merger control approval from the Austrian Federal Competition Authority. Under the terms of the agreement, the closing of this transaction triggers an upfront license fee payment of $3.95 billion by Gilead to Galapagos. In addition, Gilead has made an equity investment in Galapagos of approximately $1.1 billion (or approximately €960 million) by subscribing for new shares at a price of €140.59 per share, including issuance premium. As a result, Gilead now owns 13,589,686 ordinary shares of Galapagos, representing approximately 2
32 Leading Global Fashion and Textile Companies Make Commitments on Climate, Biodiversity and Oceans23.8.2019 07:47:00 CEST | Press release
Ahead of the G7 meeting at Biarritz from August 24-26, French President Emmanuel Macron, accompanied by Economy and Finance Minister Bruno Le Maire, Minister of Labour Muriel Pénicaud, and Deputy Minister of Ecological and Solidary Transition Brune Poirson, has invited to the Elysée Palace representatives of the 32 fashion and textile companies who have launched the Fashion Pact by his side. In April 2019, ahead of the G7 meeting, Emmanuel Macron had given François-Henri Pinault, Chairman and Chief Executive Officer of Kering (Paris:KER), a mission to bring together the leading players in fashion and textile, with the aim of setting practical objectives for reducing the environmental impact of their industry. In a historic move, given the scale and importance of the coalition that has been created, 32 leading companies from the fashion and textile industry have given themselves a set of shared objectives in the form of a Fashion Pact. The coalition includes groups and brands in Luxury,
Ethereum (ETH) Now Available on bitFlyer Buy/Sell23.8.2019 05:00:00 CEST | Press release
Cryptocurrency exchange bitFlyer has announced it is adding Ethereum (ETH) to its Buy/Sell trading platform. From today, bitFlyer Buy/Sell users across Europe and the US can send and receive ETH while ensuring they adhere to the same robust regulatory standards as bitFlyer guarantees for Bitcoin (BTC) transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190822005486/en/ Ethereum (ETH) Now Available on bitFlyer Buy/Sell (Graphic: Business Wire) Andy Bryant, Co-head and COO, bitFlyer Europe, said, “At bitFlyer, we want to offer not just the most popular coins, but the most respected ones too, which makes ETH a logical choice to expand our service offering. Not only has ETH proved itself as a useful altcoin, particularly in relation to smart contracts, it has an incredibly strong community that surrounds it. We’re committed to offering the best customer experience whilst prioritising security and regulatory standards, a
STALICLA Announces Completion of pre-IND Meeting With FDA on STP1 for Subgroup of Patients With Autism Spectrum Disorder (ASD)23.8.2019 00:00:00 CEST | Press release
STALICLA, a Swiss Biotech company, today announced the completion of its pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) on the preparation for entry of STP1 into clinical trials. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190822005559/en/ STALICLA at the Food and Drug Administration (FDA) to discuss its investigational precision medicine for Autism Spectrum Disorder (Photo: STALICLA) “We are appreciative of FDA´s technical guidance and strong interest in personalized medicine approaches for patients with Autism Spectrum Disorder. STALICLA is committed to rapidly move forward with the submission of its STP1 IND. STP1 holds the potential to become the first precision medicine for a subgroup of patients with ASD, and herald a new age for this field.” - Lynn Durham, CEO and Founder of STALICLA. ASD is a common neurodevelopmental disorder, with high level of heterogeneity, that aff
San Fang Chemical Switches to Rimini Street Support for its Oracle EBS and Oracle Database Software22.8.2019 22:00:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced that San Fang Chemical Co., Ltd., a global manufacturer and distributor of artificial leather products headquartered in Taiwan, has switched to Rimini Street support for its Oracle E-Business Suite application and Oracle Database software. In addition to immediately saving 50% of its annual maintenance costs that they were previously paying the vendor, the company can now maintain its core, robust Oracle system for a minimum of 15 years from the time that they switched to Rimini Street support with no forced upgrades. San Fang Chemical has also been able to liberate its IT resources and divert its substantial cost savings to invest in more forward-looking innovation projects to help pave the way for future growth and competitive advantage. This press release features mu
Gravity Unveils its Future Plans During Gamescom 201922.8.2019 15:46:00 CEST | Press release
Gravity Interactive, Inc., a subsidiary of Gravity Co., Ltd. (NASDAQ: GRVY) which is a leading global game company, participated in Gamescom which is one of the three largest game fairs in the world, held in Cologne, Germany from August 20th to 24th. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190822005507/en/ Gravity Interactive, Inc., a subsidiary of Gravity Co., Ltd. (NASDAQ: GRVY) which is a leading global game company, participated in Gamescom which is one of the three largest game fairs in the world, held in Cologne, Germany. At the fair, Gravity announced that it plans to launch ‘Ragnarok M: Eternal Love’ in the European region on September 4th 2019. ‘Ragnarok M: Eternal Love’ will be launched in Russia and Turkey, as well as Europe and it will be serviced in seven languages including English, Portuguese, Spanish, Russian, German, French, and Turkish. (Photo: Business Wire) On August 20th, Gravity held a presentati